Keywords: cephalon, 1st-qtr, income, soars, 75m, first, quarter
Cephalon's 1st-qtr income soars to $75M
Article | 14 May 2007
First quarter profits at US biopharmaceutical group Cephalon soared to $75.0 million from the $3.6 million it recorded in the comparable period ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
